Pharmaceutics International — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Pharmaceutics International (Pii) is a specialized CDMO with over 30 years of experience tackling complex formulation and manufacturing challenges for injectable and oral drug products. Its core value proposition is taking on difficult projects others avoid, offering services from early-stage development through commercial manufacturing, including analytical testing, aseptic fill-finish, and lyophilization. Following its 2025 acquisition by manufacturing giant Jabil, Pii is positioned to leverage greater resources and automation to scale its services for clients in the biopharma industry.

Drug Delivery

Technology Platform

Integrated CDMO services for complex drug products, specializing in formulation development, aseptic fill-finish (including lyophilization and prefilled syringes), and oral dose manufacturing for potent and sensitive molecules. Utilizes in silico modeling and phase-appropriate development.

Opportunities

Leveraging Jabil's scale, automation, and global supply chain to offer more integrated and efficient end-to-end CDMO services.

Growing demand for complex injectable and potent oral drug manufacturing, especially in oncology and biologics, aligns perfectly with Pii's core expertise.

Risk Factors

Integration challenges following the acquisition by Jabil could disrupt operations or company culture.

Intense competition in the CDMO space and the constant regulatory scrutiny inherent in sterile manufacturing pose ongoing business and reputational risks.

Competitive Landscape

Operates in a highly competitive CDMO market against large global players (e.g., Lonza, Catalent, Thermo Fisher CDMO) and numerous niche specialists. Differentiates through a focused claim on solving complex formulation and manufacturing challenges that other CDMOs may avoid, and through its new backing by Jabil's manufacturing and engineering prowess.

More companies in United States →